{"title":"Reimbursement Challenges in Europe for Innovative Therapies","authors":"J. Ehreth","doi":"10.31038/jppr.2019221","DOIUrl":"https://doi.org/10.31038/jppr.2019221","url":null,"abstract":"The thinking about the role of health care systems has been evolving over the last ten years such that there is more recognition of the importance of healthy populations on overall wealth and security [1]. At the European level and in WHO studies have shown that the positive return on investment in health systems is between 50% and 250% [2]. At the same time with the exploding advances in understanding how the body works, innovative therapies are proliferating at an ever so rapid pace [3]. What these innovations have in common that was not the case in the past is that they are more focused. Their patient populations are smaller. They are more efficient. That is to say those innovations a generation ago were targeting large populations (Block Buster drugs) with diseases for which we had a significant understanding at that time. Today as scientific understanding is digging deeper into the chemistry of the body, the challenges for health care systems have focused on the rising costs and limited budgets.","PeriodicalId":285318,"journal":{"name":"Journal of Pharmacology & Pharmaceutical Research","volume":"51 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115098793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Observations on and Challenges to Research for the Future Treatments for Envenomation","authors":"J. A. Price","doi":"10.31038/jppr.2019213","DOIUrl":"https://doi.org/10.31038/jppr.2019213","url":null,"abstract":"In this limited space I intend to make a few observations and opinions, and raise some questions, in order to stimulate thinking about future treatments for envenomation, mainly but not exclusively for the benefit of newer investigators and investigators new to this field. There is no way to be definitive completely in this short opinion piece. It seems fair to disclaim that while not all questions have simple answers, the process of consideration, including debate, stimulated in part by controversial statements and open questions, can lead to improved understanding, and hopefully better clinical outcomes.","PeriodicalId":285318,"journal":{"name":"Journal of Pharmacology & Pharmaceutical Research","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130440923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Emad Darvishi, J. B. Lissoos, C. L. Thomas, G. Woldemichael
{"title":"Mithramycin-A Induced Toxicity in HepG2 Cells is mediated by Disruption of Calcium Homeostasis","authors":"Emad Darvishi, J. B. Lissoos, C. L. Thomas, G. Woldemichael","doi":"10.31038/jppr.2019211","DOIUrl":"https://doi.org/10.31038/jppr.2019211","url":null,"abstract":"Mithramycin A is a potent inhibitor of EWS-FLI1, a transcription factor implicated in Ewings sarcoma. However, a clinical trial initiated to evaluate its efficacy revealed hepatotoxicity at doses well below those required for inhibition of EWS-FLI1 activity. In the present study, we used a chemogenomic screen against gene deletion mutants of the yeast Saccharomyces cerevisiae to generate hypothesis on its cellular mechanism of hepatotoxicity. Our findings show that it disrupts calcium homeostasis in S. cerevisiae . Studies in HepG2 cells grown in monolayer and as spheroids confirmed that it not only induced sustained elevated cytosolic Ca 2+ levels but also induced endoplasmic reticulum stress. Cells exposed to the compound were ultimately found to undergo calpain mediated apoptosis. These data suggest that mithramycin A is a direct toxin to liver cells and its toxicity is mediated, at least in part, by disruption of Ca 2+ homeostasis.","PeriodicalId":285318,"journal":{"name":"Journal of Pharmacology & Pharmaceutical Research","volume":"475 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133997271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Component of the Puzzle, When Attempting to Understand Antipsychotics: A Theoretical Study of Chemical Reactivity Indexes","authors":"Ana Martínez, R. Vargas","doi":"10.31038/jppr.2018115","DOIUrl":"https://doi.org/10.31038/jppr.2018115","url":null,"abstract":"Schizophrenia is a human condition that has attracted the attention of researchers. There is no cure for schizophrenia but several treatments can help control symptoms (hallucinations and delusions). Dopamine D2 receptor antagonists are mainly effective for the treatment of psychotic symptoms, hence the name “antipsychotic”. This study principally aims to conduct a quantum chemical analysis of one family of antipsychotics. New physical insights have attempted to explain the pharmacological action mechanism of these drugs. Two questions for which we found a possible answer are: why the Defined Daily Dose (DDD) of these drugs varies and what do we have to consider when attempting to improve the effectiveness of medications? Although DDD is a complex concept related with pharmacokinetics, in this investigation we report some insights concerning the chemical reactivity that could be useful. These drugs are antagonists of dopamine. This means that they occupy the same receptor, but refrain from activating it. We found that the more they differ from those found in dopamine, the lower DDD is required. Chemical reactivity indexes of antipsychotics should to be different from those of dopamine. These ideas represent an aspect of the complex puzzle that contributes to define the pharmacological action of antipsychotics.","PeriodicalId":285318,"journal":{"name":"Journal of Pharmacology & Pharmaceutical Research","volume":"69 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131721613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Studies on the Evaluation of Preservative Efficacy of 2-Pyrrolidone for Oral Paediatric Formulations","authors":"","doi":"10.31038/jppr.2018114","DOIUrl":"https://doi.org/10.31038/jppr.2018114","url":null,"abstract":"Pharmaceutical oral dosage forms intended to children have to be administered under liquid dosage forms. These oral liquid formulations contained into multidose containers require the addition of antimicrobial agents to avoid the growth of microorganisms. Moreover, the oral administration of poorly water soluble drugs requires the use of excipients (organic solvent, cyclodextrins, surfactants, polymers) able to improve their water solubility. 2-pyrrolidone (Soluphor ® P) a co-solvent usually used to dissolve drugs for the manufacture of parenteral dosage forms and suggested also for other administration routes, showed antimicrobial activity. To study the extent of its preservative efficacy, we determined the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) first, for bacteria ( Staphylococcus aureus , Pseudomonas aeruginosa , Escherichia coli , Enterococcus faecalis , Staphylococcus epidermidis , Staphylococcus capitis ) and for bacterial spores ( Bacillus cereus , Bacillus sphaericus , Bacillus subtilis ), then for yeast and mould ( Candida albicans , Aspergillus niger ). The results showed that 2-pyrrolidone has a bactericidal and fungistatic efficacy. Challenge tests were realized on oral aqueous paediatric formulations of vitamin D3 containing 2-pyrrolidone as a co-solvent and all known micro-organisms in such formulations were studied. The preservative efficacy of 2-pyrrolidone was observed at a dosage level of 75 mg/mL.","PeriodicalId":285318,"journal":{"name":"Journal of Pharmacology & Pharmaceutical Research","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128174565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pattern of Anti-Epileptic Drug use in Libyan Children and Their Effects on Liver Enzyme Activities","authors":"M. Bengleil, Fathi Mohamed Sherif","doi":"10.31038/jppr.2018113","DOIUrl":"https://doi.org/10.31038/jppr.2018113","url":null,"abstract":"Epilepsy is one of the most common chronic neurological disease that characterized by recurrent, spontaneous brain seizures. Anti-epileptic drug is used clinically to control the epilepsy or reduce the frequency of the attacks. Liver is the primary and main organ for drug metabolism and elimination of several drugs such as anti-epileptic drugs (AEDs). Thus, drug-induced toxicity may occur. Since liver enzymes can serve as biological markers of hepatocellular injury, this study was aimed to evaluate the effect of anti-epileptic drugs used in patients treated at the Department of Neurology in Benghazi Children Hospital, on activities of liver enzymes; aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP). Out of 58 patients selected randomly in this study 38% of them were female with age ranged from four months to five years old. Male patients were more susceptible to the adverse effects than the female patients. Mode of therapy and age of the patient did not show any effect on the levels of enzyme changes. Sodium valproate was the frequent drug used and level of ALP of the majority of patient was elevated above the normal level. Routine screening of hepatic enzymes level during the chronic use of anti-epileptic drugs is recommended and the need for obtaining baseline liver function tests is also essential before starting anti-epileptic therapy in Libyan children.","PeriodicalId":285318,"journal":{"name":"Journal of Pharmacology & Pharmaceutical Research","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131485811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yue Zhu, Zhang Ma, S. He, Ya-Lan Wang, Zong-yuan Hong
{"title":"Pharmacokinetics of Acetaminophen in the Hypothalamus of Rats Based on in vivo Microdialysis","authors":"Yue Zhu, Zhang Ma, S. He, Ya-Lan Wang, Zong-yuan Hong","doi":"10.31038/jppr.2018111","DOIUrl":"https://doi.org/10.31038/jppr.2018111","url":null,"abstract":"To explore the studying method for pharmacokinetics in the target site of drugs, the pharmacokinetic process of acetaminophen in the hypothalamus of rats was investigated. Male Sprague-Dawleyrats were anaesthetized and secured in a stereotaxic frame. A microdialysis probe was implanted into the hypothalamus and perfused with artificial cerebrospinal fluid at a flow rate of 2 μL/min. Adaptation for 1 h, rats were administrated with acetaminophen (150 mg/kg, i.p.) and microdialysates were collected continuously at 12-min intervals for 6 h. The acetaminophen concentrations in microdialysates were determined by HPLC-Ultraviolet detection (HPLC-UV), and the concentration-time profile and pharmacokinetic parameters of acetaminophen were calculated by DAS software. The results showed that the concentration-time curve of acetaminophen in the hypothalamus of rats was fitted to a one-compartment open model. The main pharmacokinetic parameters t1/2, Tmax, Cmax and AUCinf were (1.95 ± 0.59) h, (1.26 ± 0.22) h, (11.39 ± 2.17) μg/mL and (58.04 ± 18.39) μg·h/mL, respectively. In conclusion, by means of in vivo microdialysis approach, the pharmacokinetic process of acetaminophen in the hypothalamus of rats is investigated and an experimental method for studying pharmacokinetics of drugs in the target site is established, which is simple, feasible and reliable.","PeriodicalId":285318,"journal":{"name":"Journal of Pharmacology & Pharmaceutical Research","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130270023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Drug discovery: science and/or art?","authors":"D. Liberati","doi":"10.31038/jppr.2018112","DOIUrl":"https://doi.org/10.31038/jppr.2018112","url":null,"abstract":"One of the reason for such healthy and wealthy attitude is that drug discovery is not obvious nor simple nor cheap nor fast, as a rule: a good chemical could imply a fortune even in the few years of validity of the patent. A thorough knowledge of pathophysiology is required in order to design biochemistry able to heal without damaging to much. Intuition and experience are paramount, but nowadays at least a couple of approaches are keen to help.","PeriodicalId":285318,"journal":{"name":"Journal of Pharmacology & Pharmaceutical Research","volume":"195 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122521822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ensure Quality Assurance for Companies and Institutions","authors":"Boyd L. Summers","doi":"10.4172/2167-7689.1000176","DOIUrl":"https://doi.org/10.4172/2167-7689.1000176","url":null,"abstract":"","PeriodicalId":285318,"journal":{"name":"Journal of Pharmacology & Pharmaceutical Research","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2016-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129871593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Process Mapping","authors":"1. C. Y. map","doi":"10.31038/jppr.2021413","DOIUrl":"https://doi.org/10.31038/jppr.2021413","url":null,"abstract":"","PeriodicalId":285318,"journal":{"name":"Journal of Pharmacology & Pharmaceutical Research","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129923236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}